Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II/III Randomized Controlled Study of Neoadjuvant FOLFOX6 Treatment With or Without Radiation Compared to 5-Fu Based Chemoradiation in Treating Patients With Resectable Rectal Cancer

NCT01211210 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT01211210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01211210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II/III Randomized Controlled Study of Neoadjuvant FOLFOX6 Treatment With or Without Radiation Compared to 5-Fu Based Chemoradiation in Treating Patients With Resectable Rectal Cancer
Lead sponsor
Sun Yat-sen University
Phase
Phase 2/3
Overall status
Unknown status
Start date
June 30, 2010
Completion date
June 30, 2020
Enrollment
495 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer